Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 1476 - 1500 of 1595 in total
Bizelesin has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Experimental
Renzapride is currently in Phase III clinical development in the United States for the treatment of constipation-predominant irritable bowel syndrome (IBS-C). It has been suggested that renzapride is effective in the treatment of irritable bowel syndrome with alternating stool pattern. It is being developed by Alizyme of the UK.
Investigational
Investigational
Investigational
Experimental
Vet approved
AZD1981 has been used in trials studying the treatment and basic science of Asthma, Postmenopausal, Pharmakokinetic, Asthma Patients, and Drug Interaction, among others.
Investigational
BMS-777607 has been investigated for the basic science of Malignant Solid Tumour.
Investigational
Vidupiprant has been used in trials studying the treatment and basic science of Asthma.
Investigational
SAR405838 has been used in trials studying the treatment of Neoplasm Malignant.
Investigational
CEP-37440 has been used in trials studying the treatment of Solid Tumors.
Investigational
OPC-51803 is the first nonpeptide vasopressin (AVP) V(2)-receptor-selective agonist. It is a V(2)-selective agonist that produces a significant antidiuretic action after single and multiple oral dosing in AVP-deficient and normal AVP states. It is useful therapeutic drug in the treatment of hypothalamic diabetes insipidus, nocturnal enuresis, and some kinds of...
Investigational
Displaying drugs 1476 - 1500 of 1595 in total